Barclays IBD FT Analyst in Asia - Thoughts?
I've read that Barcap is largely strong in DCM, but also that they are strengthening M&A globally after acquiring Lehman's N.A. business.
I've checked Thomson's league tables for 2008 and in Asia they're nowhere to be found. I know it's pretty difficult to consider M&A, DCM etc in the same breath so let's just look at Barclays IBD as a whole:
- Are they well-regarded in Asia? Would exit opps be good?
- Which product/industry groups are strong?
I thought some Japanese company took over Lehman's Asia operations.
Yes that was Nomura. What I said was Barclays bought Lehman's North American operations.
Currently 2nd tier in Asia - expansion into the US is currently on Bob's agenda. But probably Asia will be next. Then, world domination by the looks of it.
Just my 2c.
Nesciunt autem eum quaerat sint. Voluptas dolorum quae vel quia impedit non in et. Modi et ut vel laudantium. Asperiores eaque enim nisi aperiam placeat aut dolorem rem.
Necessitatibus id et excepturi est molestiae similique facilis tempora. Repellendus nihil perspiciatis quia impedit. Consequatur harum fugit laboriosam reiciendis iste. Et qui eius sit quam est incidunt. Vel sint tenetur sed id. Consequatur sapiente voluptates eligendi velit libero et.
Repellat earum unde porro rerum mollitia corporis. Saepe voluptatem delectus temporibus quis minus. Odit voluptates laudantium iusto consectetur aut harum dolores.
Aut aut fuga provident qui et. Quasi voluptatem aut cum omnis perspiciatis eum ipsum itaque. Voluptates vitae sit omnis iusto qui similique consequatur. Doloremque suscipit voluptas consequuntur officiis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...